Major gaps exist in the ability to appropriately design pediatric clinical trials as well as construct suitable dosing guidance in pediatric populations for which drug therapy is warranted.
Pharmacometric Considerations for Guiding Pediatric Trial Designs
Major gaps exist in the ability to appropriately design pediatric clinical trials as well as construct suitable dosing guidance in pediatric populations for which drug therapy is warranted.
0 Comments